Stomach - Revision history

Michael: /* Gastric neuroendocrine tumour */

2022-01-26T15:51:09Z

Gastric neuroendocrine tumour

← Older revision		Revision as of 15:51, 26 January 2022
Line 380:		Line 380:

	==Gastric neuroendocrine tumour==		==Gastric neuroendocrine tumour==
	*[[AKA]] ''neuroendocrine tumour of the stomach''.		*[[AKA]] ''neuroendocrine tumour of the stomach'' and ''gastric NET''.
	===General===		===General===
	*Behaviour dependent on the subtype.		*Behaviour dependent on the subtype.

2019-05-28T18:37:03Z

Gastric dysplasia: split out to Stomach adenoma

2019-02-13T12:56:20Z

Stomach versus intestine: correct typo

← Older revision		Revision as of 12:56, 13 February 2019
Line 54:		Line 54:
	Notes:		Notes:
	*Intraepithelial lymphocytes in the gastric mucosa have a clear halo around 'em.<ref>Sternberg H4P 2nd Ed., P.484</ref>		*Intraepithelial lymphocytes in the gastric mucosa have a clear halo around 'em.<ref>Sternberg H4P 2nd Ed., P.484</ref>
	*Memory device: '''F'''~~olveolar~~ cells have '''f'''riends, i.e. they are close to other foveolar cells.		*Memory device: '''F'''oveolar cells have '''f'''riends, i.e. they are close to other foveolar cells.

	===Gastric antrum versus gastric body===		===Gastric antrum versus gastric body===

2018-05-02T14:16:29Z

Sleeve gastrectomy: split out

@@ Line 146: / Line 146: @@
 ====Sleeve gastrectomy====
-*Indication: morbid [[obesity]].
+{{Main|Sleeve gastrectomy}}
 =Introduction=

2018-05-02T14:11:57Z

Sign out

← Older revision		Revision as of 14:11, 2 May 2018
Line 167:		Line 167:
	<pre>		<pre>
	Partial Stomach, Sleeve Gastrectomy:		Partial Stomach, Sleeve Gastrectomy:
	- Stomach wall with abundant HELICOBACTER-LIKE ORGANISMS and moderate chronic active inflammation of the mucosa		- Stomach wall with abundant HELICOBACTER-LIKE ORGANISMS and moderate chronic active
	~~and~~ .		inflammation of the mucosa.
	- NEGATIVE for intestinal metaplasia.		- NEGATIVE for intestinal metaplasia.
	- NEGATIVE for dysplasia and NEGATIVE for malignancy.		- NEGATIVE for dysplasia and NEGATIVE for malignancy.

2018-05-02T14:11:18Z

Sign out

← Older revision		Revision as of 14:11, 2 May 2018
Line 163:		Line 163:
	- NEGATIVE for Helicobacter-like organisms.		- NEGATIVE for Helicobacter-like organisms.
	- NEGATIVE for dysplasia and NEGATIVE for malignancy.		- NEGATIVE for dysplasia and NEGATIVE for malignancy.
			</pre>

			<pre>
			Partial Stomach, Sleeve Gastrectomy:
			- Stomach wall with abundant HELICOBACTER-LIKE ORGANISMS and moderate chronic active inflammation of the mucosa
			and .
			- NEGATIVE for intestinal metaplasia.
			- NEGATIVE for dysplasia and NEGATIVE for malignancy.
	</pre>		</pre>

2018-02-07T22:46:00Z

Portal hypertensive gastropathy: split out

@@ Line 340: / Line 340: @@
 ==Portal hypertensive gastropathy==
 *Abbreviated ''PHG''.
-===General===
+{{Main|Portal hypertensive gastropathy}}
 ==Amyloidosis of the stomach==

2017-03-05T15:43:48Z

← Older revision		Revision as of 15:43, 5 March 2017
Line 701:		Line 701:
	Others:		Others:
	*CD3 (T cells) - scatter positivity.		*CD3 (T cells) - scatter positivity.
	*CD20 (B cells) +ve.		*[[CD20]] (B cells) +ve.
	*CD138 (plasma cells).		*CD138 (plasma cells).
	*kappa, lambda -- often one is predominant, suggesting clonality.		*kappa, lambda -- often one is predominant, suggesting clonality.

2015-11-08T14:58:15Z

Sleeve gastrectomy

← Older revision		Revision as of 14:58, 8 November 2015
Line 150:		Line 150:
	*[[GIST]]s are seen in 0.6% of cases (based on a series of 827 patients<ref>{{Cite journal \| last1 = Yuval \| first1 = JB. \| last2 = Khalaileh \| first2 = A. \| last3 = Abu-Gazala \| first3 = M. \| last4 = Shachar \| first4 = Y. \| last5 = Keidar \| first5 = A. \| last6 = Mintz \| first6 = Y. \| last7 = Nissan \| first7 = A. \| last8 = Elazary \| first8 = R. \| title = The True Incidence of Gastric GIST-a Study Based on Morbidly Obese Patients Undergoing Sleeve Gastrectomy. \| journal = Obes Surg \| volume = \| issue = \| pages = \| month = Jun \| year = 2014 \| doi = 10.1007/s11695-014-1336-5 \| PMID = 24965544 }}</ref>).		*[[GIST]]s are seen in 0.6% of cases (based on a series of 827 patients<ref>{{Cite journal \| last1 = Yuval \| first1 = JB. \| last2 = Khalaileh \| first2 = A. \| last3 = Abu-Gazala \| first3 = M. \| last4 = Shachar \| first4 = Y. \| last5 = Keidar \| first5 = A. \| last6 = Mintz \| first6 = Y. \| last7 = Nissan \| first7 = A. \| last8 = Elazary \| first8 = R. \| title = The True Incidence of Gastric GIST-a Study Based on Morbidly Obese Patients Undergoing Sleeve Gastrectomy. \| journal = Obes Surg \| volume = \| issue = \| pages = \| month = Jun \| year = 2014 \| doi = 10.1007/s11695-014-1336-5 \| PMID = 24965544 }}</ref>).

			=====Sign out=====
	<pre>		<pre>
	Partial Stomach, Sleeve Gastrectomy:		Partial Stomach, Sleeve Gastrectomy:

2015-09-18T14:30:19Z

Sleeve gastrectomy: tweak

← Older revision		Revision as of 14:30, 18 September 2015
Line 151:		Line 151:

	<pre>		<pre>
	Stomach, Sleeve Gastrectomy:		Partial Stomach, Sleeve Gastrectomy:
	- Stomach wall within normal limits.		- Stomach wall within normal limits.
			</pre>

			<pre>
			Partial Stomach, Sleeve Gastrectomy:
			- Stomach wall with a small quantity of INTESTINAL METAPLASIA and
			moderate (mucosa confined) chronic inactive inflammation.
			- Fundic gland polyp.
			- NEGATIVE for Helicobacter-like organisms.
			- NEGATIVE for dysplasia and NEGATIVE for malignancy.
	</pre>		</pre>